Reducing utilization costs for Medicare Advantage plans.

Learn how Kivo Health delivers 3.1x ROI for Health Plans HERE

Kivo Health delivers 3.1x ROI for health plans

Chronic obstructive pulmonary disease (COPD) is one of the most common and costly chronic conditions among Medicare Advantage plan members.

Prevalence
1 in 9
members in a Medicare Advantage plan have COPD (11.5%).
Cost
$29,564 PMPY
cost of high-risk COPD members, 2.9x more than PMPY cost of members without COPD.

Kivo Health is predicted to save $8,245 PMPY in costs, primarily by reducing inpatient and SNF costs.

$8,245 PMPY in predicted cost savings

ROI
3.1x
Projected annual savings
$9.8M
per 100,000 Medicare Advantage members

By reducing unnecessary healthcare utilization, Kivo Health delivers a projected 3.1x ROI and nearly $10M in cost savings when deployed across an MA plan with 100,000 lives.

Kivo's approach

Kivo Health virtual care solves access barriers

Kivo Health offers a virtual program so members can access unparalleled care from the comfort of their own home.

83%
Completion
90
NPS

Assessment

  • 1:1 with licensed respiratory therapist

  • Identify gops in case

  • Individualized program and goals

Rehab

  • 9-weeks

  • Aerobic and anaerobic exercise

  • Breathing techniques

  • Medication management

Assessment

  • Improved outcomes through ongoing monitoring & support

Contact us to learn more

Interested in learning how Kivo Health can help reduce utilization costs and MLR among Medicare Advantage members?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
  1. https://www.atsjournals.org/doi/10.1164/rccm.201606-1162PP#:~:text=The%20ranges%2035%E2%80%9354%2C%2055,are%20age%20groups%2C%20in%20years.&text=In%202010%2C%20the%20COPD%20cohort,were%20directly%20related%20to%20COPD.
  2. https://www.resmedjournal.com/article/S0954-6111(08)00143-1/fulltext